A high-throughput cost-efficient in vitro platform for the screening of immune senomodulators
Caterina Carraro, Timo Zajac, Sophie K. Lindenberg, Jacqueline Leidner, Alice Ragogna, Bidour Hussein, Sophie Mueller, Martina van Uelft, Heidi Theis, Elena De Domenico, Marc Beyer, Monique M.B. Breteler, Joachim Ludwig Schultze, Anna C. Aschenbrenner, Jonas Schulte-Schrepping, Lorenzo Bonaguro
The paper develops an in vitro platform to screen immune senomodulators using human-derived immune cells, enabling personalized anti-aging treatments through multi-scale molecular analysis.
bioRxiv · Mar 13, 2026 · PreprintSystems Biology